Department of Specialized, Experimental and Diagnostic Medicine, Microbiology Unit, Laboratory of Virology, St. Orsola Polyclinic, University of Bologna, Bologna, Italy.
Department of Medical Sciences, Section of Infectious Diseases and Dermatology, University of Ferrara, Ferrara, Italy.
Antivir Ther. 2020;25(2):111-114. doi: 10.3851/IMP3352.
Cytomegalovirus (CMV) infection is a major complication in immunocompromised patients, including those with autoimmune diseases. Here, we describe the first case of granulomatosis with polyangiitis treated with steroids and cyclophosphamide, complicated by a multidrug-resistant (MDR) CMV infection in presence of weak antiviral cellular immunity. Since reports regarding CMV infection in rheumatological patients are rarely described and no guidelines on its management exist, the described case contributes to identify potential strategies to predict the risk of CMV disease and developing of MDR-CMV in these patients, through virological and immunological surveillance.
巨细胞病毒 (CMV) 感染是免疫功能低下患者(包括自身免疫性疾病患者)的主要并发症。在这里,我们描述了首例接受类固醇和环磷酰胺治疗的肉芽肿性多血管炎患者,并发存在抗病毒细胞免疫较弱的多药耐药(MDR)CMV 感染。由于关于风湿性疾病患者 CMV 感染的报道很少,并且没有关于其管理的指南,因此所描述的病例有助于通过病毒学和免疫学监测来确定预测这些患者发生 CMV 疾病和 MDR-CMV 的潜在策略。